Sage
HerbalAlso called · 12 names▾▴
common sage, Spanish sage, Salvia officinalis, Salvia lavandulaefolia, Salvia fruticosa, Salvia bertolonii, Salvia pratensis, Salvia nemorosa, sage leaf, Salviae officinalis folium, sage essential oil, sage oil
Herbal supplement (menopause symptoms and memory)
Herbs and supplements are not FDA-approved before sale. About these sources
- Tea
- Capsule/tablet
- Liquid extract
- Essential oil
- Topical
- Food / spice
Research strength: 1 / 5
EMA says sage leaf products are not recommended during pregnancy because safety has not been established and data are insufficient. NCCIH warns that thujone in common sage may have harmful effects during pregnancy. A mouse study fed female mice a diet with 0.25% sage essential oil for two weeks before mating and found a change in embryo cell distribution on day 4; it did not test human pregnancy, miscarriage, or birth defects. A 2013 human survey included sage use but did not report pregnancy outcomes separately for sage users. NCCIH says amounts commonly found in food are likely not a concern, but its pregnancy warning does not set a dose or separate sage forms. Ask your provider about your situation.
Last reviewed: 2026-10-16
Sources
- NCCIH: Sage: Usefulness and SafetyUS government
- European Medicines Agency: EU herbal monograph on Salvia officinalis leafEU agencyEuropean guidance
- Domaracký et al., Physiological Research 2007: Mouse preimplantation embryo studyUS government
- Al-Ramahi et al., Journal of Ethnopharmacology 2013: Palestinian pregnancy surveyUS government
- European Medicines Agency: HMPC minutes, 06-08 July 2026EU agencyEuropean guidance
Research strength: 1 / 5
EMA says sage leaf products are not recommended during pregnancy because safety has not been established and data are insufficient. NCCIH warns that thujone in common sage may have harmful effects during pregnancy. The mouse study fed oil before mating and measured embryos before implantation, so it does not report a second-trimester effect. A 2013 human survey included sage use but did not report outcomes separately for sage users. NCCIH says amounts commonly found in food are likely not a concern, but its pregnancy warning does not separate sage forms. Ask your provider about your situation.
Last reviewed: 2026-10-16
Sources
- NCCIH: Sage: Usefulness and SafetyUS government
- European Medicines Agency: EU herbal monograph on Salvia officinalis leafEU agencyEuropean guidance
- Domaracký et al., Physiological Research 2007: Mouse preimplantation embryo studyUS government
- Al-Ramahi et al., Journal of Ethnopharmacology 2013: Palestinian pregnancy surveyUS government
- European Medicines Agency: HMPC minutes, 06-08 July 2026EU agencyEuropean guidance
Research strength: 1 / 5
EMA says sage leaf products are not recommended during pregnancy because safety has not been established and data are insufficient. NCCIH warns that thujone in common sage may have harmful effects during pregnancy. The mouse study fed oil before mating and measured embryos before implantation, so it does not report a late-pregnancy effect. A 2013 human survey included sage use but did not report outcomes separately for sage users. NCCIH says amounts commonly found in food are likely not a concern, but its pregnancy warning does not separate sage forms. Ask your provider about your situation.
Last reviewed: 2026-10-16
Sources
- NCCIH: Sage: Usefulness and SafetyUS government
- European Medicines Agency: EU herbal monograph on Salvia officinalis leafEU agencyEuropean guidance
- Domaracký et al., Physiological Research 2007: Mouse preimplantation embryo studyUS government
- Al-Ramahi et al., Journal of Ethnopharmacology 2013: Palestinian pregnancy surveyUS government
- European Medicines Agency: HMPC minutes, 06-08 July 2026EU agencyEuropean guidance
Sage — Breastfeeding
Research strength: 1 / 5
LactMed reports no human data on sage use by nursing mothers or infants and no scientific studies of its effect on milk supply. EMA says lactation use of medicinal sage leaf is not recommended because data are insufficient, while NCCIH says little is known about sage during breastfeeding. A 2015 rat study found growth in breast tissue after sage extract, but it did not measure human milk production. A 2025 sheep study of a combined sage, parsley, and echinacea supplement found no significant prolactin change, but it did not isolate sage or study people. A separate case report described seizures after accidental direct sage-oil exposure in a newborn and toddler, not exposure through milk. Ask your provider about your situation.
Last reviewed: 2026-10-16
Sources
- LactMed (NIH): SageUS government
- European Medicines Agency: EU herbal monograph on Salvia officinalis leafEU agencyEuropean guidance
- NCCIH: Sage: Usefulness and SafetyUS government
- Monsefi et al., Avicenna Journal of Phytomedicine 2015: Rat mammary gland studyUS government
- Kutlu and Akbulut, Tropical Animal Health and Production 2025: Lactating ewe supplement studyUS government
- Halicioglu et al., Pediatric Neurology 2011: Sage-oil exposure case reportUS government
Pregnancy
Human pregnancy evidence is limited. A 2013 cross-sectional survey of 300 women in Palestine found sage was among the herbs used by pregnant respondents: 120 women used herbs, and 55% of herb users reported sage. The paper found no statistically significant difference in pregnancy outcomes between all herb users and non-users, but it did not report sage-specific outcomes. A 2007 mouse study fed females a diet containing 0.25% sage essential oil before mating; it reported a change in how preimplantation embryos were distributed by cell count on day 4. This animal study did not test human use, live birth, miscarriage, or birth defects. EMA's 2016 final assessment report said no reproductive or developmental toxicity studies were available, but it did not cite the 2007 mouse study. The EMA's 2016 monograph says pregnancy safety has not been established and does not recommend medicinal sage leaf products because data are insufficient. NCCIH warns that thujone in common sage may have harmful effects during pregnancy. In July 2026, EMA's HMPC decided not to revise the monograph because it found no new relevant data that would change it.
Breastfeeding
LactMed reports no human data on sage use by nursing mothers or infants and no scientific studies measuring sage's effect on milk supply. A 2015 study gave 14 female rats a 30 mg/kg/day hydroalcoholic sage extract for 30 days; mammary alveolar buds, lobules, and ducts increased, but milk production was not measured. A 2025 randomized study assigned 80 lactating Merino ewes to a combined supplement containing sage and other herbs or control; the study found no significant treatment effect on serum prolactin (P=0.209). Because the supplement included parsley and echinacea, the effect of sage alone cannot be determined, and animal results do not establish human breastfeeding effects. The 2011 newborn and toddler seizure cases involved accidental direct sage-oil exposure, not breast-milk exposure. EMA says lactation safety for sage leaf has not been established and recommends against medicinal use because of insufficient data. NCCIH says little is known about sage during breastfeeding.
Common sage is Salvia officinalis, but the name sage also covers other Salvia species. Sage products may use leaves, liquid or dry extracts, or essential oil, and their composition can vary. NCCIH says amounts commonly found in food are likely not a concern, while its pregnancy warning notes possible harmful effects from thujone in common sage. EMA's leaf monograph covers tea, extracts, and topical or mouth preparations; its separate public statement concerns concentrated sage oil with high thujone levels. LactMed notes that sage may be misidentified or adulterated and that supplement labels may not match the actual ingredients or amounts.
What was tested
The 2013 Palestinian survey questioned 300 women after delivery; 120 reported herb use during pregnancy and 55% of herb users reported sage, but the paper did not break pregnancy outcomes out by sage. The 2007 animal study fed ICR female mice a diet containing 0.25% sage essential oil for 2 weeks before mating and assessed embryo cell distribution on day 4 of pregnancy. The 2015 rat study used 30 mg/kg/body weight of hydroalcoholic sage extract for 30 days and examined estrous cycles, hormones, and mammary tissue, not milk volume. The 2025 ewe study tested a combined sage, parsley, and echinacea supplement in 80 lactating Merino ewes and measured prolactin and reproductive outcomes. No human study measuring sage levels in milk, infant exposure through milk, or sage's effect on human milk production was identified in the sources reviewed.
Does the evidence include a reproductive or developmental study of common sage?
- Source A says
- EMA's 2016 final assessment report said no reproductive or developmental toxicity studies of Salvia officinalis were available. In July 2026, the HMPC decided that no new relevant data required a monograph revision. (European Medicines Agency: Final assessment report on Salvia officinalis leaf and essential oil, Revision 1, European Medicines Agency: HMPC minutes, 06-08 July 2026)
- Source B says
- Domaracký et al. (2007) tested sage essential oil in mice before mating and reported a negative influence on the distribution of preimplantation embryos by cell number. (Domaracký et al., Physiological Research 2007: Effects of selected plant essential oils on mouse preimplantation embryos)
- Why they differ
- The 2016 EMA report did not cite this study and stated that no reproductive study was available. Domaracký tested essential oil and an early embryo marker, not live birth or structural malformations. The 2026 minutes say the review report will be published as an addendum after editorial review, so its treatment of the 2007 paper is not yet clear.
- What the evidence shows overall
- The animal study is a signal for concentrated sage oil, not evidence of human miscarriage or birth defects and not a basis to apply the result to food seasoning or every sage preparation. Human pregnancy outcomes specific to sage remain unclear, while EMA's advice against medicinal sage reflects insufficient data.
- NCCIH distinguishes amounts commonly found in food from high-dose or long-term use and notes that common sage contains thujone. (NCCIH)
- EMA's leaf monograph says medicinal sage leaf products are not recommended during pregnancy or lactation because safety has not been established and data are insufficient. (European Medicines Agency)
- EMA's public statement says the benefits of sage oil do not outweigh its risks because the oil can provide high thujone exposure. (European Medicines Agency)
General research, not specific to pregnancy.
LactMed says thujone and camphor can affect the nervous system at high doses, and EMA says sage oil may cause seizures at high doses. A 2011 case report described seizures after accidental direct sage-oil exposure in a newborn and toddler; it did not involve breast milk.
- EMA reports that sage oil has high thujone levels and that high doses may cause seizures; it says the benefits of sage oil do not outweigh its risks. (European Medicines Agency: Public statement on Salvia officinalis essential oil)
- LactMed notes that thujone and camphor can affect the nervous system at high doses. NCCIH distinguishes common food amounts from high-dose or long-term use. (LactMed (NIH): Sage, NCCIH: Sage: Usefulness and Safety)
- A 2011 case report describes a newborn and a toddler who had seizures after accidental direct exposure to sage oil; the report does not describe exposure through breast milk. (Halicioglu et al., Pediatric Neurology 2011: Accidental sage-oil exposure cases)
- NCCIH: Sage: Usefulness and SafetyUS governmentSecondaryIndependent check
- LactMed (NIH): SageUS governmentSecondaryPage dated 2025-07-15Independent check
- European Medicines Agency: EU herbal monograph on Salvia officinalis leaf, Revision 1EU agencySecondaryPage dated 2016-09-20European guidance
- European Medicines Agency: Public statement on Salvia officinalis essential oilEU agencySecondaryPage dated 2016-02-02European guidance
- European Medicines Agency: Final assessment report on Salvia officinalis leaf and essential oil, Revision 1EU agencySecondaryPage dated 2016-09-20European guidance
- European Medicines Agency: HMPC minutes, 06-08 July 2026EU agencySecondaryPage dated 2026-09-24European guidance
- Al-Ramahi et al., Journal of Ethnopharmacology 2013: Use of herbal medicines during pregnancy in Palestinian womenUS governmentPrimaryIndependent check
- Domaracký et al., Physiological Research 2007: Effects of selected plant essential oils on mouse preimplantation embryosUS governmentPrimaryIndependent check
- Monsefi et al., Avicenna Journal of Phytomedicine 2015: Sage extract and rat mammary glandsUS governmentPrimaryIndependent check
- Kutlu and Akbulut, Tropical Animal Health and Production 2025: Sage-containing supplement in lactating ewesUS governmentPrimaryIndependent check
- Halicioglu et al., Pediatric Neurology 2011: Accidental sage-oil exposure casesUS governmentPrimaryIndependent check
Last reviewed 2026-10-16
Independent check 2026-10-16
Not yet clinician-reviewed
Ask your provider about your situation.
Related
- Black Cohosh
- Red Clover
- Ginkgo